Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

LISA V BLAIR

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family

NPI
1699149856
CMS profile
10790368
Location
NASHVILLE, TN

General Payments · PY2021–2024

$4,143.09

  • Reported across 237 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$342.91

18 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $342.91 18

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $107.12 6
PY2022 $1,953.29 120
PY2023 $1,739.77 93
PY2024 $342.91 18

Payment records · PY2024 (18)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $16.43 04/18/2024 Food and Beverage Undisputed 01/23/2026 1125201824 CMS
Amgen Inc. $18.59 03/11/2024 Food and Beverage Undisputed 01/23/2026 1117508806 CMS
AstraZeneca Pharmaceuticals LP $15.75 02/01/2024 Food and Beverage Undisputed 01/23/2026 1104454822 CMS
AstraZeneca Pharmaceuticals LP $16.90 03/27/2024 Food and Beverage Undisputed 01/23/2026 1105869381 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $16.16 03/21/2024 Food and Beverage Undisputed 01/23/2026 1118114001 CMS
Exact Sciences Corporation $18.47 02/21/2024 Food and Beverage Undisputed 01/23/2026 1114562892 CMS
GlaxoSmithKline, LLC. $18.05 03/07/2024 Food and Beverage Undisputed 01/23/2026 1116127531 CMS
Lilly USA, LLC $15.25 02/13/2024 Food and Beverage Undisputed 01/23/2026 1135741036 CMS
Novo Nordisk Inc $20.44 01/30/2024 Food and Beverage Undisputed 01/23/2026 1100462558 CMS
Novo Nordisk Inc $20.28 02/15/2024 Food and Beverage Undisputed 01/23/2026 1100318346 CMS
Novo Nordisk Inc $22.33 03/27/2024 Food and Beverage Undisputed 01/23/2026 1100308597 CMS
Novo Nordisk Inc $24.25 04/04/2024 Food and Beverage Undisputed 01/23/2026 1100363229 CMS
Otsuka America Pharmaceutical, Inc. $20.18 01/23/2024 Food and Beverage Undisputed 01/23/2026 1119027866 CMS
PFIZER INC. $22.46 02/06/2024 Food and Beverage Undisputed 01/23/2026 1131439055 CMS
PFIZER INC. $19.17 02/27/2024 Food and Beverage Undisputed 01/23/2026 1131509380 CMS
PFIZER INC. $20.42 03/08/2024 Food and Beverage Undisputed 01/23/2026 1131453170 CMS
PFIZER INC. $17.42 03/20/2024 Food and Beverage Undisputed 01/23/2026 1131500035 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $20.36 04/17/2024 Food and Beverage Undisputed 01/23/2026 1153510479 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.